Last reviewed · How we verify
ATMX
At a glance
| Generic name | ATMX |
|---|---|
| Sponsor | University of Arizona |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD (PHASE4)
- Effectiveness of ATMX in Treating Adolescents With ADHD and SUD (PHASE4)
- Autonomic Correlates of Impulsivity for Preschool Children With Attention Deficit Hyperactivity Disorder (ADHD) (PHASE4)
- Atomoxetine Pilot Study in Preschool Children With ADHD (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |